Priya Rastogi, MD

Chief Executive Officer, NSABP Foundation
Medical Director, NSABP Foundation
Assoc. Professor of Medicine, University of Pittsburgh

Priya Rastogi, MD is an Associate Professor of Medicine at the University of Pittsburgh, School of Medicine, and a medical oncologist at Magee-Womens Hospital of UPMC. She is the Chief Executive Officer and Medical Director with the NSABP Foundation.

Her clinical research interests include Phase II and Phase III neoadjuvant and adjuvant breast cancer clinical trials. She has been involved with the development and implementation of clinical trials through NRG Oncology and the NSABP Foundation. Dr. Rastogi has published on breast cancer in traditional medical journals. Representative publications can be found in the New England Journal of Medicine and the Journal of Clinical Oncology. She is the NRG Oncology Breast Cancer Committee Chair and a member of the NRG Oncology Breast Cancer Committee Working Group. She is also Chair of the NRG Oncology Early Career Mentorship Subcommittee.

APPOINTMENTS

  • UPMC/University of Pittsburgh
  • 2000-2003 University of Pittsburgh Hematology/Oncology Fellowship
  • 2003–2011 University of Pittsburgh Assistant Professor of Medicine
  • 2011-Present University of Pittsburgh Associate Professor of Medicine
  • NSABP FOUNDATION
  • 2005-2006 NSABP Foundation FRP Steering Committee, Member
  • 2006-2008 NSABP Foundation Assistant Director
  • 2008-2011 NSABP Foundation Associate Director
  • 2011-2020 NSABP Foundation Senior Associate Medical Director
  • 2020-Present NSABP Foundation Medical Director
  • 2006-2011 NSABP Foundation Vice Chair for Medical Affairs
  • 2011-Present NSABP Foundation Chair for Medical Affairs
  • 2005-Present NSABP Foundation Breast Committee Working Group, Member
  • 2022-Present NSABP Foundation Chief Executive Officer
  • NRG ONCOLOGY
  • 2012-2013 NRG Oncology Scientific Publications Working Group Committee, Member
  • 2013-Present NRG Oncology Publications Committee, Member
  • 2014-Present NRG Oncology Breast Cancer Committee, Member
  • 2014-Present NRG Oncology Breast Cancer Committee Working Group, Member
  • 2014-2026 Co-Chair NRG Oncology New Investigator Committee
  • 2026-Present Chair, NRG Oncology Early Career Mentorship Subcommittee
  • 2026-Present NRG Oncology Breast Cancer Committee Chair
  • OTHER
  • 2012-Present Steering Committee for CALOR, Member
  • 2012-Present Katherine Trial Operations Committee, Member
  • 2013 ASCO Scientific Program Abstract Review Committee
  • 2014 ASCO Cancer Education Committee, Member
  • 2014 ASCO Breast HER/ER Track Leader
  • 2013-Present Olympia Trial Executive Committee, Member
  • 2013-Present Olympia Trial Steering Committee, Member
  • 2016-2018 NCI Breast Cancer Steering Committee MBC Endpoint Working Group, Member
  • 2017-Present Executive Committee for Lilly Adjuvant Abemaciclib Trial, Member
  • 2017-Present Steering Committee for Lilly Adjuvant Abemaciclib Trial, Member